Aquinox Pharmaceuticals Inc. added Baker Brothers Investments representatives Kelvin Neu and Richard Levy to its board.

Neu joins the board as a class III director, with a term expiring at the company's 2017 annual meeting. Levy will serve as a class II director until the 2019 annual meeting.

Baker Brother Investments is the company's largest stockholder, where Neu works as managing director and Levy as senior adviser.